Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Haas

Showing results (41-50 of 107) with videos related to

Pageof 11
Sort By:
Pediatric Rheumatology Online Journal|February 14, 2018
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary resultsLea Höfel, Bruno Eppler, Magdalena Storf, et al.
Pediatric Rheumatology Online Journal|August 13, 2022
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritisLudwig Zeller, Pascal N Tyrrell, Stella Wang, et al.
Pediatric Rheumatology Online Journal|April 12, 2022
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patientsMarie-Therese Holzer, Giovanni Almanzar, Robert Woidich, et al.
Arthritis Research & Therapy|April 16, 2020
Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in GermanyArnd Heiligenhaus, Jens Klotsche, Martina Niewerth, et al.
Pediatric Rheumatology Online Journal|February 5, 2016
Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control studySwaantje Barth, Jenny Schlichtiger, Betty Bisdorff, et al.
Annals of the Rheumatic Diseases|May 1, 2015
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)Jens Klotsche, Martina Niewerth, Johannes-Peter Haas, et al.
BMC Pregnancy and Childbirth|February 21, 2014
Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-studyInes Kersten, Anja Erika Lange, Johannes Peter Haas, et al.
Pediatric Rheumatology Online Journal|May 24, 2017
Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general populationJenny Schlichtiger, Johannes-Peter Haas, Swaantje Barth, et al.
Plos One|April 27, 2016
Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General PopulationSwaantje Barth, Johannes-Peter Haas, Jenny Schlichtiger, et al.
Rheumatology International|June 6, 2016
Functional limitations in children and adolescents suffering from chronic pain: validation and psychometric properties of the German Functional Disability Inventory (FDI-G)Martin Offenbächer, Niko Kohls, Lynn Walker, et al.
Pageof 11

Showing results (41-50 of 107) with videos related to

Sort By:
Pageof 11
Pediatric Rheumatology Online Journal|February 14, 2018
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing - treatment protocol and preliminary resultsLea Höfel, Bruno Eppler, Magdalena Storf, et al.
Pediatric Rheumatology Online Journal|August 13, 2022
α2-fraction and haptoglobin as biomarkers for disease activity in oligo- and polyarticular juvenile idiopathic arthritisLudwig Zeller, Pascal N Tyrrell, Stella Wang, et al.
Pediatric Rheumatology Online Journal|April 12, 2022
Mitigated suppressive function of regulatory T cells (Treg) upon Th17-inducing cytokines in oligo- and polyarticular Juvenile Idiopathic Arthritis (JIA) patientsMarie-Therese Holzer, Giovanni Almanzar, Robert Woidich, et al.
Arthritis Research & Therapy|April 16, 2020
Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in GermanyArnd Heiligenhaus, Jens Klotsche, Martina Niewerth, et al.
Pediatric Rheumatology Online Journal|February 5, 2016
Association between drug intake and incidence of malignancies in patients with Juvenile Idiopathic Arthritis: a nested case-control studySwaantje Barth, Jenny Schlichtiger, Betty Bisdorff, et al.
Annals of the Rheumatic Diseases|May 1, 2015
Long-term safety of etanercept and adalimumab compared to methotrexate in patients with juvenile idiopathic arthritis (JIA)Jens Klotsche, Martina Niewerth, Johannes-Peter Haas, et al.
BMC Pregnancy and Childbirth|February 21, 2014
Chronic diseases in pregnant women: prevalence and birth outcomes based on the SNiP-studyInes Kersten, Anja Erika Lange, Johannes Peter Haas, et al.
Pediatric Rheumatology Online Journal|May 24, 2017
Education and employment in patients with juvenile idiopathic arthritis - a standardized comparison to the German general populationJenny Schlichtiger, Johannes-Peter Haas, Swaantje Barth, et al.
Plos One|April 27, 2016
Long-Term Health-Related Quality of Life in German Patients with Juvenile Idiopathic Arthritis in Comparison to German General PopulationSwaantje Barth, Johannes-Peter Haas, Jenny Schlichtiger, et al.
Rheumatology International|June 6, 2016
Functional limitations in children and adolescents suffering from chronic pain: validation and psychometric properties of the German Functional Disability Inventory (FDI-G)Martin Offenbächer, Niko Kohls, Lynn Walker, et al.
Pageof 11